This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Hoeven, K. H.
Right arrow Articles by Body, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Hoeven, K. H.
Right arrow Articles by Body, B.

Next Article 

Clinical and Vaccine Immunology, December 2008, p. 1751-1754, Vol. 15, No. 12
1071-412X/08/$08.00+0     doi:10.1128/CVI.00254-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Comparison of Three Enzyme-Linked Immunosorbent Assays for Detection of Immunoglobulin G Antibodies to Tetanus Toxoid with Reference Standards and the Impact on Clinical Practice{triangledown}

Karen H. van Hoeven,1* Connie Dale,1 Phil Foster,2 and Barbara Body2

The Binding Site, Inc., San Diego, California,1 LabCorp, Burlington, North Carolina2

Received 14 July 2008/ Returned for modification 7 August 2008/ Accepted 26 September 2008

Accurate determination of the concentrations of immunoglobulin G (IgG) antibody to tetanus toxoid is important in order to evaluate the immunogenicity of tetanus toxoid vaccines, determine immune competence in individual patients, and measure the prevalence of immunity in populations. The performance of three commercially available enzyme-linked immunosorbent assays (ELISAs) for IgG antibodies to tetanus toxoid were evaluated. Serially diluted NIBSC 76/589 and TE-3 human tetanus IgG immunoglobulin international reference standards were analyzed in quadruplicate using ELISAs manufactured by The Binding Site, Inc. (VaccZyme); Scimedx; and Euroimmun. In addition, IgG antibodies to tetanus toxoid were measured in 83 deidentified serum specimens using each manufacturer's ELISA. Each ELISA provided linear results when evaluated with the reference preparations. The Binding Site ELISA provided results that closely corresponded to the reference preparations (y = 1.09x – 0.08), whereas the Scimedx ELISA gave results that were consistently lower (y = 0.21x – 0.07) and the Euroimmun ELISA gave results that were consistently higher (y = 1.5x + 0.30) than the reference preparation concentrations. Using the recommended cutoff for each ELISA (<0.10 IU/ml), the overall agreement of all of the ELISA methods was 78%. Three of eighty-three (3.6%) human serum samples demonstrated inadequate immunity with all three assays. The Binding Site ELISA yielded nonprotective antibody concentrations in only these 3 samples, whereas 19 samples (22.9%) according to the Scimedx ELISA and 6 samples (7.2%) according to the Euroimmun ELISA demonstrated nonprotective concentrations. The performance characteristics of ELISAs for tetanus immunoglobulin titers were manufacturer dependent, and the differences translated into important disparities in reported results.

* Corresponding author. Mailing address: The Binding Site, Inc., 5889 Oberlin Dr., Ste. 101, San Diego, CA 92121. Phone: (267) 402-7569. Fax: (413) 612-9683. E-mail: karen.vanhoeven{at}thebindingsite.com

{triangledown} Published ahead of print on 8 October 2008.

Clinical and Vaccine Immunology, December 2008, p. 1751-1754, Vol. 15, No. 12
1071-412X/08/$08.00+0     doi:10.1128/CVI.00254-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»